MORE►
BioNTX
BioNTX 2025 Rising Stars honorees seen at a recent investor dinner hosted by NexPoint. [Photo: BioNTX]
BioNTX Celebrates North Texas Startup ‘Rising Stars’ at Investor Dinner
by Sandra Engelland | Dec 18, 2025
Eight North Texas startups were honored as 2025 BioNTX Rising Stars, in a program designed to elevate emerging companies by providing visibility, credibility, and direct access to investors, industry leaders, and strategic partners.
by Lance Murray |
Oct 8, 2025
The partnership establishes a cross-continental bridge between India and North Texas to support "clinical research, translational science, and long-term global impact," BioNTX said.
MORE►
by Glenn Hunter |
Sep 24, 2025
At Dallas’ iC3 Summit, leaders from Texas and across the U.S. pointed to AI, new state initiatives like Proposition 14, and potential federal reforms as keys to speeding innovation and keeping America competitive in life sciences.
MORE►
by David Seeley |
Aug 19, 2025
Part of the 2025 iC³ Life Science & Healthcare Innovation Summit to be held September 16-17 in Dallas, the showcase pitch event is designed to connect university researchers with potential investors, industry executives, and strategic partners. This is the first year the showcase has expanded beyond Texas.
MORE►
GenrAb CEO Larry Tiffany, who is leading the company's push to bring a first-in-class neuroprotective therapy into the clinic, also serves as Executive Chairman and Director at Medcura. [Sources: Medcura photo; iStock background; DI Studio]
UT Southwestern Spinout Emerges From Stealth With $5.6M to Push ‘First in Class’ Neuroprotective Therapy Into the Clinic
by Quincy Preston | Apr 24, 2025
Dallas biotech GenrAb is developing an antibody therapy that aims to protect brain cells under stress—the kind of damage that leads to disability in diseases like MS and ALS. The therapy, found in the spinal fluid of real patients, is now showing promise in animal models and moving toward human trials.
MORE►
by David Seeley |
Feb 12, 2025
Advanced Therapies Week 2025—a conference focused on the latest innovations in cell and gene therapies, regenerative medicine, and other biotechnologies—attracted industry leaders, researchers, and visionaries to Dallas' Kay Bailey Hutchison Convention Center in late January. Organized by London-based Phacilitate, the 4-day conference acted as a "collaborative hub" showcasing the intersection of cutting-edge science, transformative healthcare solutions, and dynamic regional collaboration.
MORE►
by Lance Murray |
Oct 2, 2024
Renibus CEO Jeff Keyser will be acknowledged as the award recipient at the 10th Annual iC³ Life Science & Healthcare Innovation Summit on Thursday, the first day of the Oct. 3-4 summit at the Loews Arlington Hotel & Convention Center.
MORE►
by Lance Murray |
Sep 26, 2024
The Tech Transfer Showcase spotlights life science innovation at universities and strengthens the development of future leaders and entrepreneurs, BioNTX said. Here are the six university finalists who'll be pitching at the summit.
MORE►
The 2024 BioNTX iC3 Summit will be held Oct. 3-4 at the new Loews Arlington Convention Center in Arlington, which is connected to the Loews Arlington Hotel in the heart of the city's Entertainment District. [Image: Loews Arlington Hotel]
10th Annual iC3 Summit: BioNTX Brings Life Science Leaders to Brand-New Loews Arlington Venue in October
by Lance Murray | Jun 17, 2024
The 2024 iC3 Summit, hosted by nonprofit BioNTX, is set to welcome over 1,000 industry professionals, researchers, entrepreneurs, and investors for its largest gathering yet. The event's formula—Innovation = Capital × Collaboration × Commercialization,—underscores its mission to drive breakthroughs through strategic partnerships and investments.
The 2024 iC3 Summit, hosted by nonprofit BioNTX, is set to welcome over 1,000 industry professionals, researchers, entrepreneurs, and investors for its largest gathering yet. The event's formula—Innovation = Capital × Collaboration × Commercialization—underscores its mission to drive breakthroughs through strategic partnerships and investments.
MORE►
by David Seeley |
Nov 14, 2023
GEW North Texas—which kicked off Monday and runs through Sunday November 19—is part of Global Entrepreneurship Week, held in cities worldwide one week each November. The movement aims to inspire entrepreneurs around the globe while fostering connections and increasing collaboration within their ecosystems.
MORE►
by Dallas Innovates | Staff Report |
Nov 3, 2023
BioNTX, a leading nonprofit bioscience and healthcare innovation organization in North Texas, has appointed Jon Weidanz to its board of directors. Weidanz brings extensive experience as an immunology researcher, academic leader, biotech entrepreneur, and founder....
MORE►
by Quincy Preston |
Sep 28, 2023
With a theme of “Innovation, Capital, Collaboration, Commercialization”—or iC³—the summit unites researchers, entrepreneurs, investors, corporations, and support organizations to forge the relationships that drive progress.
MORE►
BioNTX's Dr. Aaron BenComo (left) and Swiss American CDMO CEO Komel Grover [Courtesy photos]
Swiss American CDMO and BioNTX To Launch the Biotechnology and Healthcare Industry Alliance of North Texas
by Lance Murray | Jun 14, 2023
The alliance's first event will be held June 22 in a bid to champion a next-generation, industry-led workforce partnership for North Texas. The alliance seeks to bring together industry trade and manufacturing ecosystems, the organizations said—and it will be working with Dallas College and other partner institutions to help make it happen.
MORE►
by Lance Murray |
Feb 13, 2023
The new two-story lab and office building will offer "the first institutional-quality space" in the DFW market, according to marketing materials.
MORE►
by Quincy Preston and David Seeley |
Dec 19, 2022
Co-founders Paul Stewart and Frank Murdock started up SkinStasis Skin Care earlier this year to meet "a big unmet need" in the cold sore/herpes virus field, where they say there's been "no real new pharmaceutical development" for over 20 years.
Working out of BioLabs at Pegasus Park, they teamed up with Irving's Cosmetic Laboratories to launch NextLeap—which uses tranexamic acid to shorten the time to recovery of normal appearance to as little as 24 to 48 hours, the co-founders say.
Working out of BioLabs at Pegasus Park, they teamed up with Irving's Cosmetic Laboratories to launch NextLeap—which uses tranexamic acid to shorten the time to recovery of normal appearance to as little as 24 to 48 hours, the co-founders say.
MORE►
by Kevin Cummings |
Sep 26, 2022
After a rigorous process, the top six applications to the Tech Transfer Office Showcase at BioNTX's iC3 life science summit were invited to pitch live at BioNTX's life science summit. Industry experts rated, graded, and discussed the technologies prior to the pitches
"We want to cultivate technologies that are coming out of the university ecosystem here—and we want them to stay here," said Chad Ronholdt, managing director at NVB Ventures.
MORE►
